292 related articles for article (PubMed ID: 8855937)
1. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
[TBL] [Abstract][Full Text] [Related]
2. Calculation of relative binding free energies and configurational entropies: a structural and thermodynamic analysis of the nature of non-polar binding of thrombin inhibitors based on hirudin55-65.
Wang J; Szewczuk Z; Yue SY; Tsuda Y; Konishi Y; Purisima EO
J Mol Biol; 1995 Oct; 253(3):473-92. PubMed ID: 7473728
[TBL] [Abstract][Full Text] [Related]
3. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
4. Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH59 side chain of the inhibitor.
Tsuda Y; Szewczuk Z; Wang J; Yue SY; Purisima E; Konishi Y
Biochemistry; 1995 Jul; 34(27):8708-14. PubMed ID: 7612610
[TBL] [Abstract][Full Text] [Related]
5. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
Myles T; Le Bonniec BF; Betz A; Stone SR
Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A
Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436
[TBL] [Abstract][Full Text] [Related]
8. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
9. Hirudin C-terminal fragments inhibit thrombin induced neutrophil chemotaxis.
Rowand JK; Marucha P; Berliner LJ
Thromb Haemost; 1992 Mar; 67(3):289-91. PubMed ID: 1641817
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
11. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
Shabareesh P; Kaur KJ
Chem Biol Drug Des; 2016 Jul; 88(1):129-41. PubMed ID: 26850929
[TBL] [Abstract][Full Text] [Related]
12. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis.
Yue SY; DiMaio J; Szewczuk Z; Purisima EO; Ni F; Konishi Y
Protein Eng; 1992 Jan; 5(1):77-85. PubMed ID: 1631048
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
Yue SY; Konishi Y
Drug Des Discov; 1994 Jul; 12(1):1-17. PubMed ID: 7578804
[TBL] [Abstract][Full Text] [Related]
15. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099
[TBL] [Abstract][Full Text] [Related]
16. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
[TBL] [Abstract][Full Text] [Related]
18. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-bound conformation of the C-terminal fragments of hirudin determined by transferred nuclear Overhauser effects.
Ni F; Konishi Y; Scheraga HA
Biochemistry; 1990 May; 29(18):4479-89. PubMed ID: 2350549
[TBL] [Abstract][Full Text] [Related]
20. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
